Latin America Advisor | How Effectively Is Mexico Fighting the Covid Pandemic?

Q: Mexico’s Health Ministry acknowledged last month in a report that the country’s true number of coronavirus-related deaths may exceed 321,000, a nearly 60 percent increase from the official tally. The figure includes 120,000 “excess” deaths that were previously unaccounted for due to reasons including a lack of testing and unreported cases of Covid-19. What is the real state of the pandemic in Mexico, and what major limitations in the country’s public health system has it exposed? How well has Mexico’s government planned for vaccination rollout? With legislative and local elections scheduled for June, will the new statistics have political consequences? 

A: Carin Zissis, editor-in-chief of AS/COA online:

On the Saturday before the start of Semana Santa, Mexico’s Health Ministry quietly revealed devastating excess death figures, even as the confirmed tally already meant the second-highest per capita death toll in Latin America after Peru. The scale of tragedy is hard to pin down, given a public health strategy with one of the lowest coronavirus test rates in the world. The lack of testing left thousands of Mexicans watching loved ones die at home, unable to confirm Covid-19 as the cause. Communication has been another hurdle. While the Health Ministry urges people to stay home or mask up, the message from the top isn’t always clear. The country’s senior coronavirus official went on a beach vacation when contagion was at its worst. President Andrés Manuel López Obrador has rarely worn a mask in public, and catching the virus didn’t convince him to start. When it comes to the vaccine rollout, news is also mixed. On Christmas Eve, Mexico was among the first Latin American countries to administer the vaccine and has secured contracts for enough doses to cover 129 percent of its population. Given the government’s schedule to complete vaccinations by March 2022, it should administer 500,000 doses daily, but it is falling far short of that mark. As of Easter Sunday, only 1 percent of Mexicans had been fully vaccinated. June midterms serve as another vaccination deadline. A March poll shows AMLO’s approval runs higher among the vaccinated. With legislative control in play and, given AMLO’s figurehead role, his party would benefit if his government can pick up the vaccination pace.

Read the full Q&A. 

AS/COA Online | LatAm in Focus: Vaccines and Variants a Year into the Pandemic

AS/COA Online · Vaccines and Variants a Year into the Pandemic

February marks a year since the first coronavirus cases were confirmed in the Americas and the virus has left a scar, claiming more than a million lives. Now the pandemic has entered a new phase, one in which countries are trying to roll out vaccines as variants threaten to undermine the protection those vaccines offer.

“We are encountering a problem that nobody is safe until everybody is safe,” says Dr. Roselyn Lemus-Martin, a COVID-19 researcher with a PhD in molecular biology from Oxford University. She explains that Latin America—and the world at large—is in a race against time to get as many people immunized as possible before the variants spread. “With these new variants, it’s going to take us a while to get to herd immunity.”

Meanwhile, a lack of transparency about vaccines can undermine public confidence in immunizations. Lemus-Martin has gained an audience in Mexico for her use of social media to explain the science behind both vaccines and variants, as well as how mechanisms such as COVAX work. She tells AS/COA’s Carin Zissis why there was a concern with Russia’s Sputnik V—for which countries such as Argentina, Bolivia, and Mexico have acquired contracts—and how a new article in The Lancet is “good news for Latin America” as a study found that the vaccine has a 91.6 percent efficacy rate.